Skip to main content
Table of Contents
Print

Are there any risks associated with high doses of cannabis for fibromyalgia? 

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Using higher amounts of cannabis than necessary can pose important safety concerns for patients with fibromyalgia, Being informed about high dose risks helps in making better choices and enhancing fibromyalgia safety. Although cannabis is not typically linked to fatal overdoses, inappropriate usage can still lead to significant discomfort or complications. 

Understanding the potential drawbacks of elevated cannabis dosing 

Here are key risks linked to excessive cannabis intake and how they might influence fibromyalgia care: 

Enhanced Psychoactive Effects 

High doses, especially of THC can trigger confusion, paranoia, or anxiety, making everyday routines harder to manage. 

Cognitive Impairment 

Heavily dosed cannabis may lead to memory lapses, reduced attention span, or slowed reaction times. 

Increased Fatigue 

Rather than relieving symptoms, an overuse of cannabis may contribute to excessive tiredness, affecting motivation and daily activities. 

Tolerance and Overuse Patterns 

Frequent high doses can lead to tolerance. Patients may gradually escalate their dosage without realising, potentially undermining long-term fibromyalgia safety. 

Physical Discomfort 

Overconsumption may cause nausea, dizziness, or unsteady balance, symptoms that can become especially challenging with fibromyalgia. 

High doses also raise the risk of cannabis effects overlapping poorly with daily pain management, causing more problems than relief. To reduce these risks, always monitor your dosage carefully and consult medical professionals experienced in cannabinoid care. 

Remember: more isn’t always better. Sticking to the right dosage helps safeguard your health and supports smoother fibromyalgia treatment. 

If you’re exploring cannabis treatment options for fibromyalgia, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Fibromyalgia. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories